FDA reopens CBD public comment period indefinitely
The Food and Drug Administration (FDA) published a notice in the Federal Register stating that it has reopened the comment period on the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.
Top